SBC SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated, together with its subsidiaries, provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and Singapore. The company offers advertising and marketing services across social media networks; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals; leasehold improvement services; and design services for clinics, medical equipment, and medical consumables procurement. It also provides loyalty program management, labor and function supporting, and management consulting services; and IT software solutions, as well as engages in franchising activities; and distributes medical equipment and devices, implants, injection materials, other medical consumables, skin care and beauty products, and cosmetic products to franchisee clinics for resale to clinic customers. In addition, the company offers surgical and non-surgical surgeries that include breast augmentation; liposuction; rejuvenation treatments, such as treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. Further, it owns and operates treatment centers under the SBC brand. SBC Medical Group Holdings Incorporated was founded in 2000 and is headquartered in Irvine, California.…
Industry Peers
Consulting ServicesKey Statistics
About SBC Medical Group Holdings (NASDAQ: SBC)
›
SBC Medical Group Holdings (NASDAQ: SBC) is listed on Nasdaq, where its shares trade in USD. It belongs to the Consulting Services industry, part of the Industrials sector, and reports about 863 employees.
The shares were at 5.600 USD on 19 November 2026, up 76.1% over 52 weeks. Its 52-week range is 2.780 USD to 7.380 USD: the price is 24.1% below the high and 101.4% above the low.
At a market capitalisation of 574.43M USD, it trades at 11.0 times trailing earnings and 9.7 times forward earnings. The median trailing P/E of its 19 largest Consulting Services peers is 26.5, a discount of 59% for SBC.
SBC Medical Group Holdings reports return on equity of 20.5%, an operating margin of 39.9% and revenue up 35.1% year over year.
It holds more cash than debt, a net cash position of 158.70M USD. Its Piotroski F-score is 4 out of 9, an average reading of its financial health. 4 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 10.00 USD is 78.6% above the current price.